生长激素抑制激素分泌瘤

• 作 者: 罗照田 梁荩忠
• 机 构: 四川医学院附属医院,四川医学院附属医院,
• 出 处: 国外医学(内科学分册)
• 发表日期: 1981年03期
• 关键词: 生长抑制素 胰高血糖素血症 脂肪泻 胰腺 胰岛素 高血糖 胰高血糖素 胰岛 胆石症 内分泌细胞

自1977年以来,由胰腺 D 细胞所产生的生长激素抑制激素分泌瘤(Somatostatinoma,又称胰腺 D 细胞瘤,以下简称生长抑制素瘤)正逐渐引起人们的注意。迄今为止,这种以高血糖、低胰岛素和低胰高血糖素血症、脂肪泻和胆石症为主要特征的生长抑制素瘤,国外已有6例报道,其中多数为手术中或手术后意外发现。最近,已有人在术前作出诊断,并进行了广泛的术前研究。

Somatostatinoma (Somatostatinoma, also known as Pancreatic D-cell tumor, hereinafter referred to as Somatostatin), which is produced by pancreatic D-cells, has drawn increasing attention since 1977. So far, this high-glycemic, hypoglycemic and hypoglycemicmia, steatorrhea and cholelithiasis as the main feature of somatostatin, foreign countries have been reported in 6 cases, most of which were surgery or surgery after the accident Find. Recently, some people have made preoperative diagnosis and conducted extensive preoperative research.